Pfizer CEO calls US drug price plan 'negotiation with a gun to your head' https://ift.tt/0qLcYQs

Drugs likely to be among the first subject to negotiation include Pfizer's breast cancer treatment Ibrance and the blood thinner Eliquis, which Pfizer shares with Bristol Myers Squibb. The pharmaceutical industry says the law will result in a loss of profits that will force drugmakers to pull back on developing groundbreaking new treatments.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/WiqbzFt